To be a Global Leading Crop Protection Company
Stock code: 301035
Stock code: 301035 | Stock abbreviation: Rainbow Chemical | Announcement No.: 2023-064 |
SHANDONG WEIFANG RAINBOW CHEMICAL CO.,LTD
The Third Quarter Report of 2023
The Company and all members of the Board of Directors warrant that the contents of the Quarterly Report are true, accurate andcomplete, without false records, misleading statements or major omissions.
Important notes:
1. The Board of Directors, Board of Supervisors, directors, supervisors and senior management warrant that the contents of theQuarterly Report are true, accurate and complete, without false records, misleading statements or major omissions, and shall bearindividual and collective legal liabilities.
2. The legal representative of the Company, the chief accountant in charge, and the chief of the accounting institution (accountingsupervisor), stated that the financial report in the Quarterly Report is true, accurate and complete.
3. Whether the Third Quarter Report is audited
□ Yes ? No
To be a Global Leading Crop Protection Company
I. Key Financial Data(I) Key accounting data and financial indexesWhether the Company needs to retroactively adjust or restate the accounting data of previous years
□ Yes ? No
Q3 2023 | Year-on-year increase or decrease | From the start of 2023 to the end of Q3 2023 | Year-on-year increase or decrease | |
Operating income (RMB) | 3,475,391,281.15 | -15.99% | 8,518,893,985.17 | -28.51% |
Net profit attributable to shareholders of the Company (RMB) | 297,230,701.58 | -28.93% | 721,621,504.36 | -44.74% |
Net profit attributable to shareholders of the Company excluding non-recurring gains and losses (RMB) | 296,836,814.30 | -29.25% | 716,335,101.21 | -45.43% |
Net cash flow from operating activities (RMB) | -- | -- | -246,078,338.95 | -111.63% |
Basic earnings per share (RMB/Share) | 1.07 | -29.61% | 2.60 | -45.26% |
Diluted earnings per share (RMB/Share) | 1.06 | -29.80% | 2.58 | -45.45% |
Weighted average return on net assets | 4.68% | -2.51% | 11.42% | -12.51% |
End of Q3 2023 | End of 2022 | Year-on-year increase or decrease | ||
Total assets (RMB) | 14,228,247,904.23 | 11,598,874,181.42 | 22.67% | |
Equity attributable to shareholders of the Company (RMB) | 6,504,920,188.55 | 6,184,265,166.56 | 5.19% |
(II) Items and amounts of non-recurring gains and losses? Applicable □ Not applicable
Unit: RMB
Item | Amount of Q3 2023 | Amount from the start of 2023 to the end of Q3 2023 | Notes |
Gain and loss on disposal of non-current assets (including the write-off portion of asset impairment provision) | 17,577.08 | -3,080,973.27 | |
Government subsidies included in current gains and losses (closely related to normal operational business of the Company, excluding the continuous government subsidies of certain amount or quota complying with national policies) | 1,104,399.55 | 6,695,597.76 | |
Profits and losses in fair value | 32,909.02 | 100,467.38 |
To be a Global Leading Crop Protection Company
from trading financial assetsand trading financialliabilities, as well asinvestment income fromdisposal of trading financialassets, trading financialliabilities, and financial assetsavailable for sale, except foreffective hedging businessrelated to the normaloperation of the Company
from trading financial assets and trading financial liabilities, as well as investment income from disposal of trading financial assets, trading financial liabilities, and financial assets available for sale, except for effective hedging business related to the normal operation of the Company | |||
Other non-operating revenue and expenditure other than those mentioned above | -687,097.64 | 1,732,957.74 | |
Less: Affected amount of income tax | 6,273.09 | 148,651.93 | |
Affected amount of minority shareholders' equity (after tax) | 67,627.64 | 12,994.53 | |
Total | 393,887.28 | 5,286,403.15 | -- |
Other gains and losses items that meet the definition of non-recurring gains and losses:
□ Applicable ? Not applicable
There are no other gains and losses items of the Company that meet the definition of non-recurring gains and losses.Reasons for the non-recurring profit and loss items listed in Explanatory Announcement on Information Disclosure for CompaniesOffering Their Securities to the Public No.1 - Non-recurring Gains and Losses recognized as recurring gains and losses items
□ Applicable ? Not applicable
There is no circumstance where the non-recurring profit and loss items listed in Explanatory Announcement on InformationDisclosure for Companies Offering Their Securities to the Public No.1 - Non-recurring Gains and Losses are recognized as recurringgains and losses items.(III) Changes to key accounting data and financial indexes and reasons? Applicable □ Not applicable
1. Balance sheet items
Unit: RMB
Item | September 30, 2023 | December 31, 2022 | Change (%) | Reason for change |
Pre-payments | 178,838,899.86 | 75,294,804.30 | 137.52% | Mainly due to the increase in prepayment for purchasing raw materials during the reporting period |
Other receivables | 48,246,140.24 | 33,525,890.70 | 43.91% | Mainly due to the increase in reserve fund for business travels during the reporting period |
Inventory | 2,950,638,881.55 | 1,657,230,533.12 | 78.05% | Mainly due to the increase in local inventory of some overseas subsidiaries during the reporting period |
Other current assets | 444,183,849.66 | 184,823,557.40 | 140.33% | Mainly due to the increase in input tax credit of subsidiaries and in prepaid taxes during the reporting period |
Other non-current assets | 109,793,027.67 | 69,616,034.81 | 57.71% | Mainly due to the increase in payment for construction projects during the reporting period |
To be a Global Leading Crop Protection CompanyShort-term loan
Short-term loan | 1,758,518,957.06 | 404,206,509.66 | 335.05% | Mainly due to the increase in bank borrowings during the reporting period |
Accounts payable | 1,232,792,267.87 | 753,042,513.89 | 63.71% | Mainly due to the increase in credit purchases during the reporting period |
Contract liability | 98,164,136.73 | 46,035,630.83 | 113.24% | Mainly due to the increase in advance payments from customers during the reporting period |
Lease liability | 12,739,026.34 | 8,595,962.05 | 48.20% | Mainly due to the increase in office leasing caused by the establishment of more new overseas subsidiaries during the reporting period |
2. Income statement items
Unit: RMB
Item | January-September 2023 | January-September 2022 | Change (%) | Reason for change |
Operating cost | 6,591,428,361.19 | 9,425,611,062.95 | -30.07% | Mainly due to the decrease in cost due to the price decrease of most of the active pharmaceutical ingredient products during the reporting period |
Financial expenses | -46,575,991.60 | -436,359,035.46 | 89.33% | Mainly due to the decrease in exchange gains caused by the fluctuation of exchange rates during the reporting period |
Investment returns | -228,488,390.61 | -60,492,810.75 | -277.71% | Mainly due to investment losses from disposal of derivative financial assets during the reporting period |
Income from changes in fair value | 53,774,061.86 | -399,356,767.11 | -113.47% | Mainly due to changes in the fair value of derivative financial assets during the reporting period |
Credit impairment losses | -43,601,963.15 | -80,290,630.61 | 45.69% | Mainly due to credit impairment losses on accounts receivable during the reporting period |
Asset impairment losses | 486,336.57 | 1,738,356.82 | -72.02% | Mainly due to the reserve for the decline of inventories during the reporting period |
Gains from asset disposal | 850,034.53 | 126,624.97 | 571.30% | Mainly due to the increase in income from disposal of non-current assets during the reporting period |
Non-operating income | 11,943,433.62 | 23,203,007.30 | -48.53% | Mainly due to losses from scrapping of non-current assets during the reporting period |
Income tax expenses | 113,258,125.87 | 201,047,731.59 | -43.67% | Mainly due to the decrease in profits during the reporting period |
3. Cash flow statement items
Unit: RMB
Item | January-September 2023 | January-September 2022 | Change (%) | Reason for change |
Net cash flow from operating activities | -246,078,338.95 | 2,115,819,098.24 | -111.63% | Mainly due to the decrease in cash received from the sale of goods and the provision of services |
Net cash flow in investment activities | -641,070,393.53 | -194,536,750.54 | -229.54% | Mainly due to investment expenditures in new and continued construction projects |
Net cash flow from financing activities | 411,177,977.26 | -1,278,718,840.25 | 132.16% | Mainly due to the increase in cash received from bank borrowings |
To be a Global Leading Crop Protection Company
II. Shareholder Information(I) The number of common shareholders, the number of preferred shareholders whose voting rights havebeen restored and the shareholdings of the top ten shareholders
Unit: Share
Number of common shareholders as of the end of Q3 2023 | 6,260 | Number of preferred shareholders whose voting rights have been restored as of the end of Q3 2023 (if any) | 0 | |||
Shareholding of the top ten shareholders | ||||||
Shareholder name | Shareholder nature | Shareholding ratio | Shareholding quantity | Quantity of restricted shares held | Pledge, mark or freeze | |
Share status | Quantity | |||||
Shandong Rainbow Investment Co., Ltd. | Domestic non-state-owned legal person | 41.47% | 114,911,237 | 114,911,237 | Pledge | 22,880,000 |
KONKIA INC | Overseas legal person | 22.08% | 61,191,800 | 61,191,800 | ||
Shandong Rainbow Agriculture Investment Co., Ltd. | Domestic non-state-owned legal person | 4.73% | 13,105,690 | 13,105,690 | ||
Orient Securities Company Limited - Zhonggeng Value Pioneer Equity Securities Investment Fund | Other | 3.46% | 9,590,684 | 0 | ||
Industrial and Commercial Bank of China Co., Ltd. - BOCOM Schroder Trend Priority Hybrid Securities Investment Fund | Other | 3.22% | 8,927,604 | 0 | ||
Jinan Xinbo Investment Co., Ltd. | Domestic non-state-owned legal person | 2.83% | 7,840,686 | 0 | Pledge | 6,827,700 |
Pei Xubo | Domestic natural person | 2.81% | 7,799,613 | 0 | ||
China Merchants Bank Co., Ltd. - BOCOM Schroder Qicheng Hybrid Securities Investment Fund | Other | 1.08% | 3,004,957 | 0 | ||
Yuanxin (Zhuhai) Private Equity Fund Management Co., Ltd. - Yuanxin China Value Growth No. 9 Private Securities Investment Fund | Other | 0.56% | 1,548,824 | 0 | ||
China Construction Bank Corporation - Guotai Great Health Equity Securities | Other | 0.53% | 1,461,288 | 0 |
To be a Global Leading Crop Protection Company
Investment Fund
Investment Fund | |||||
Shareholding of top ten shareholders of unrestricted shares | |||||
Shareholder name | Quantity of unrestricted shares held | Type and quantity of shares | |||
Type | Quantity | ||||
Orient Securities Company Limited - Zhonggeng Value Pioneer Equity Securities Investment Fund | 9,590,684 | RMB-denominated common shares | 9,590,684 | ||
Industrial and Commercial Bank of China Co., Ltd. - BOCOM Schroder Trend Priority Hybrid Securities Investment Fund | 8,927,604 | RMB-denominated common shares | 8,927,604 | ||
Jinan Xinbo Investment Co., Ltd. | 7,840,686 | RMB-denominated common shares | 7,840,686 | ||
Pei Xubo | 7,799,613 | RMB-denominated common shares | 7,799,613 | ||
China Merchants Bank Co., Ltd. - BOCOM Schroder Qicheng Hybrid Securities Investment Fund | 3,004,957 | RMB-denominated common shares | 3,004,957 | ||
Yuanxin (Zhuhai) Private Equity Fund Management Co., Ltd. - Yuanxin China Value Growth No. 9 Private Securities Investment Fund | 1,548,824 | RMB-denominated common shares | 1,548,824 | ||
China Construction Bank Corporation - Guotai Great Health Equity Securities Investment Fund | 1,461,288 | RMB-denominated common shares | 1,461,288 | ||
Hong Kong Securities Clearing Company Ltd. | 1,332,438 | RMB-denominated common shares | 1,332,438 | ||
Yuanxin (Zhuhai) Private Equity Fund Management Co., Ltd. - CITIC Capital China Value Growth No. 1 Private Securities Investment Fund | 1,155,045 | RMB-denominated common shares | 1,155,045 | ||
Guotai Asset Management Co., Ltd. - Social Security Fund 421 Portfolio | 1,136,866 | RMB-denominated common shares | 1,136,866 | ||
Explanation of the above-mentioned shareholder relationship or concerted action | 1. Shandong Rainbow Investment Co., Ltd., KONKIA INC and Shandong Rainbow Agriculture Investment Co., Ltd. are enterprises controlled by Wang Wencai, Sun Guoqing and Qiu Hongbing, the actual controllers of the Company. 2. Apart from that, the Company does not know whether the top ten shareholders and top ten shareholders of unrestricted shares are associated or are persons acting in concert under the Measures for the Administration of the Takeover of Listed Companies. | ||||
Engagement of the top 10 shareholders in securities margin trading business (if any) | As of the end of this reporting period: 1. Pei Xubo holds 5,877,311 shares through the customer credit transaction guarantee securities account of securities company; 2. Yuanxin (Zhuhai) Private Equity Fund Management Co., Ltd. - Yuanxin China Value Growth No. 9 Private Securities Investment Fund holds 1,548,824 shares through the customer credit trading guarantee securities account of security company; 3. Yuanxin (Zhuhai) Private Equity Fund Management Co., Ltd. - CITIC Capital China Value Growth No. 1 Private Securities Investment Fund holds 155,000 shares through the customer credit transaction guarantee securities account of security company. |
To be a Global Leading Crop Protection Company
(II) The number of preferred shareholders of the Company and the shareholdings of the top ten preferredshareholders
□ Applicable ? Not applicable
(III) Changes in restricted shares
□ Applicable ? Not applicable
III. Other Important Matters
□ Applicable ? Not applicable
IV. Quarterly Financial Statements(I) Financial statements
1. Consolidated balance sheet
Prepared by: Shandong Weifang Rainbow Chemical Co., Ltd.
September 30, 2023
Unit: RMB
Item | September 30, 2023 | January 1, 2023 |
Current assets: | ||
Monetary funds | 3,502,488,026.65 | 3,793,952,509.17 |
Deposit reservation for balance | ||
Lending to banks and other financial institutions | ||
Financial assets held for trading | 6,000,000.00 | 8,542,688.56 |
Derivative financial assets | ||
Notes receivable | 55,864,770.98 | 59,112,584.14 |
Accounts receivable | 4,156,296,823.04 | 3,201,703,461.53 |
Receivables financing | 1,058,894.00 | 680,000.00 |
Pre-payments | 178,838,899.86 | 75,294,804.30 |
Premium receivable | ||
Re-insurance accounts receivable | ||
Reserves for re-insurance contract receivable | ||
Other receivables | 48,246,140.24 | 33,525,890.70 |
Including.: Interest receivable | ||
Dividends receivable | ||
Financial assets purchased under resale agreement | ||
Inventory | 2,950,638,881.55 | 1,657,230,533.12 |
Contracted assets | ||
Assets held for sale | ||
Non-current assets that mature within one year | ||
Other current assets | 444,183,849.66 | 184,823,557.40 |
Total current assets | 11,343,616,285.98 | 9,014,866,028.92 |
Non-current assets: | ||
Disbursed loans and advances | ||
Debt investments | ||
Other debt investment | ||
Long-term receivables |
To be a Global Leading Crop Protection Company
Long-term equity investment
Long-term equity investment | 1,340,768.22 | 1,669,386.12 |
Other equity instrument investment | ||
Other non-current financial assets | ||
Investment real estate | 8,668,227.79 | 9,136,334.57 |
Fixed assets | 1,951,308,387.59 | 1,691,830,176.47 |
Construction in progress | 364,946,441.64 | 360,840,138.91 |
Productive biological assets | ||
Oil and gas assets | ||
Assets with rights of use | 16,209,020.94 | 15,379,959.49 |
Intangible assets | 217,541,129.67 | 226,245,165.26 |
Development expenditure | ||
Goodwill | 94,866,025.56 | 94,866,025.56 |
Long-term deferred expenses | 27,318,987.35 | 31,898,939.40 |
Deferred income tax assets | 92,639,601.82 | 82,525,991.91 |
Other non-current assets | 109,793,027.67 | 69,616,034.81 |
Total non-current assets | 2,884,631,618.25 | 2,584,008,152.50 |
Total assets | 14,228,247,904.23 | 11,598,874,181.42 |
Current liabilities: | ||
Short-term loan | 1,758,518,957.06 | 404,206,509.66 |
Borrowings from the central bank | ||
Borrowing from banks and financial institutions | ||
Financial liabilities held for trading | ||
Derivative financial liabilities | 63,418,370.94 | 122,183,523.97 |
Notes payable | 3,796,759,622.02 | 3,367,152,536.58 |
Accounts payable | 1,232,792,267.87 | 753,042,513.89 |
Advance receipts | 254,920.26 | |
Contract liability | 98,164,136.73 | 46,035,630.83 |
Financial assets sold for repurchase | ||
Deposits and interbank deposits received | ||
Amount received from agency trading of securities | ||
Amount received from agency underwriting of securities | ||
Payroll payable | 154,907,267.17 | 191,738,722.30 |
Taxes payable | 132,101,081.27 | 106,896,314.07 |
Other payables | 51,324,022.78 | 43,899,535.81 |
Including: Interests payable | ||
Dividends payable | ||
Charges and commissions payable | ||
Re-insurance accounts payable | ||
Liabilities held for sale | ||
Non-current liabilities due within one year | 12,921,281.56 | 21,399,902.40 |
Other current liabilities | 58,419,518.22 | 59,862,778.90 |
Total current liabilities | 7,359,326,525.62 | 5,116,672,888.67 |
Non-current liabilities: | ||
Provision for insurance contracts | ||
Long-term loan | 12,840,802.47 | 17,176,777.87 |
Bonds payable | ||
Including: Preferred shares | ||
Perpetual bonds | ||
Lease liability | 12,739,026.34 | 8,595,962.05 |
Long-term payables | ||
Long-term payroll payable | ||
Accrued liabilities | ||
Deferred income | 12,224,307.69 | 13,755,569.25 |
Deferred income tax liabilities | 64,079,380.79 | 55,449,975.77 |
Other non-current liabilities |
To be a Global Leading Crop Protection Company
Total non-current liabilities
Total non-current liabilities | 101,883,517.29 | 94,978,284.94 |
Total liabilities | 7,461,210,042.91 | 5,211,651,173.61 |
Owner’s equity: | ||
Share capital | 277,115,744.00 | 277,115,744.00 |
Other equity instruments | ||
Including: Preferred shares | ||
Perpetual bonds | ||
Capital reserve | 2,337,590,533.98 | 2,301,293,600.92 |
Less: Treasury stock | ||
Other comprehensive income | 3,527,842.62 | 5,821,782.13 |
Special reserve | 36,280,194.42 | 19,551,007.62 |
Surplus reserve | 158,674,657.07 | 158,674,657.07 |
General risk reserve | ||
Undistributed profit | 3,691,731,216.46 | 3,421,808,374.82 |
Total owners' equity attributed to parent company | 6,504,920,188.55 | 6,184,265,166.56 |
Minority shareholder’s interest | 262,117,672.77 | 202,957,841.25 |
Total owner’s equity | 6,767,037,861.32 | 6,387,223,007.81 |
Total liabilities and owners’ equity | 14,228,247,904.23 | 11,598,874,181.42 |
Legal Representative: Wicky Wang | Chief Accountant in Charge: Xing Bingpeng | Chief of Accounting Institution: Zhang Baolin |
2. Consolidated income statement from the start of 2023 to the end of Q3 2023
Unit: RMB
Item | Amount incurred in Q3 2023 | Amount incurred in Q3 2022 |
I. Gross Operating Income | 8,518,893,985.17 | 11,915,662,694.56 |
Including: Operating income | 8,518,893,985.17 | 11,915,662,694.56 |
Interest income | ||
Premium earned | ||
Handling charges and commissions income | ||
II. Total Operating Costs | 7,417,203,067.22 | 9,822,444,784.16 |
Including: Costs of business | 6,591,428,361.19 | 9,425,611,062.95 |
Interest expenses | ||
Handling charges and commission expenses | ||
Surrender value | ||
Net payments for insurance claims | ||
Net withdrawal of reserve for insurance responsibility contracts | ||
Expenditures of policy dividend | ||
Re-insurance expense | ||
Taxes and surcharges | 38,950,885.80 | 32,485,279.48 |
Sales expenses | 234,290,589.90 | 188,674,684.79 |
Management expenses | 358,656,911.50 | 308,254,477.92 |
R&D expenditures | 240,452,310.43 | 303,778,314.48 |
Financial expenses | -46,575,991.60 | -436,359,035.46 |
Including: Interest expenses | 48,622,622.61 | 12,752,415.52 |
Interest income | 41,169,941.04 | 23,243,044.73 |
To be a Global Leading Crop Protection Company
Add: Other incomes | 6,025,597.76 | 4,853,353.35 |
Income from investment (“-” for loss) | -228,488,390.61 | -60,492,810.75 |
Including: Income from investment in associated enterprises and joint ventures | -328,617.90 | -85,804.37 |
Income recognized at termination of financial assets measured at amortized cost | ||
Foreign exchange gain ("-" fro loss) | ||
Net exposure hedging income ("-" for loss) | ||
Income from changes in fair value ("-" for loss) | 53,774,061.86 | -399,356,767.11 |
Credit impairment losses ("-" for loss) | -43,601,963.15 | -80,290,630.61 |
Asset impairment losses ("-" for loss) | 486,336.57 | 1,738,356.82 |
Gains from asset disposal ("-" for loss) | 850,034.53 | 126,624.97 |
III. Operating Profit ("-" for loss) | 890,736,594.91 | 1,559,796,037.07 |
Add: Non-operating income | 10,413,134.78 | 10,303,761.73 |
Less: Non-operating expenses | 11,943,433.62 | 23,203,007.30 |
IV. Total Profit Before Tax (“-” for total losses) | 889,206,296.07 | 1,546,896,791.50 |
Less: Income tax expenses | 113,258,125.87 | 201,047,731.59 |
V. Net Profit ("-" for net loss) | 775,948,170.20 | 1,345,849,059.91 |
(I) Classification by business continuity | ||
1. Net profit from continuing operations (“-” for net loss) | 775,948,170.20 | 1,345,849,059.91 |
2. Net profit from discontinued operations (“-” for net loss) | ||
(II) Classification by ownership | ||
1. Net profit attributable to shareholders of the parent company (net loss marked with "-") | 721,621,504.36 | 1,305,889,184.58 |
2. Profit and loss of minority shareholders (net loss marked with "-") | 54,326,665.84 | 39,959,875.33 |
VI. Net Amount after Tax of Other Comprehensive Income | 7,917,823.34 | 3,712,236.45 |
Net amount of other comprehensive income after tax attributed to the owners of parent company | -2,293,939.51 | 3,602,015.69 |
(I) Other comprehensive income that cannot be reclassified into profit or loss | ||
1. Changes due to re-measurement on defined benefit plan | ||
2. Other comprehensive income that cannot be converted into profit and loss under the equity method | ||
3. Changes in fair value of other equity instrument investments | ||
4. Changes in the fair value of the credit risk of the enterprise | ||
5. Other | ||
(ii) Other comprehensive income that will be reclassified into profit and loss | -2,293,939.51 | 3,602,015.69 |
1. Other comprehensive income that can be converted to profit or loss under the equity method | ||
2. Changes in fair value for other investment |
To be a Global Leading Crop Protection Company
on bonds
on bonds | ||
3. Amount of financial assets reclassified into other comprehensive income | ||
4. Provision for credit impairment of other creditor's rights investment | ||
5. Cash flow hedge reserve | ||
6. Difference of foreign currency financial statement translation | -2,293,939.51 | 3,602,015.69 |
7. Other | ||
Net amount of other comprehensive income after tax attributed to minority shareholders | 10,211,762.85 | 110,220.76 |
VII. Total Comprehensive Income | 783,865,993.54 | 1,349,561,296.36 |
(I) Total comprehensive income attributed to parent company owners | 719,327,564.85 | 1,309,491,200.27 |
(II) Total comprehensive income attributed to minority shareholders | 64,538,428.69 | 40,070,096.09 |
VIII. Earnings per Share: | ||
(i) Basic earnings per share | 2.60 | 4.75 |
(ii) Diluted earnings per share | 2.58 | 4.73 |
For business combination under the same control in the current period, the net profit of the merged party before the businesscombination is RMB , and the net profit of the merged party in the previous period is RMB .
Legal Representative: Wicky Wang | Chief Accountant in Charge: Xing Bingpeng | Chief of Accounting Institution: Zhang Baolin |
3. Consolidated cash flow statement from the start of 2023 to the end of Q3 2023
Unit: RMB
Item | Amount incurred in Q3 2023 | Amount incurred in Q3 2022 |
I. Cash Flows Generated from Operating Activities: | ||
Cash received from sales of goods and services | 7,644,397,757.22 | 10,331,084,547.51 |
Net increase in deposit from customers and interbank | ||
Net increase in borrowing from central bank | ||
Net increase in borrowings from other financial institutions | ||
Cash receipts from premiums under direct insurance contracts | ||
Net cash receipts from re-insurance business | ||
Net cash receipts from policyholders' deposits and investments | ||
Cash receipts from interest, handling fees and commissions | ||
Net increase in capital borrowed from banks and other financial institutions | ||
Net increase in repurchase business capital | ||
Net cash received from securities trading brokerage | ||
Cash receipts from tax refunds | 638,665,075.70 | 763,158,589.71 |
Cash received relating to other operating activities | 52,853,991.83 | 47,785,370.79 |
Subtotal of cash inflow in business activities | 8,335,916,824.75 | 11,142,028,508.01 |
Cash payments for goods acquired and services received | 7,238,805,183.22 | 7,603,969,243.17 |
Net increase in customer loans and advances |
To be a Global Leading Crop Protection CompanyNet increase in deposits in central bank andinterbank
Net increase in deposits in central bank and interbank | ||
Cash payments for original insurance contract claims | ||
Net increase in lending funds from banks and other financial institutions | ||
Cash payments for interest, fee and commission | ||
Cash payments for insurance policyholder dividends | ||
Cash payments to employees and on behalf of employees | 508,142,139.78 | 375,679,053.03 |
Cash payments for taxes | 234,809,967.31 | 370,658,836.48 |
Other cash payments relating to operating activities | 600,237,873.39 | 675,902,277.09 |
Subtotal of cash outflow in business activities | 8,581,995,163.70 | 9,026,209,409.77 |
Net cash flow from operating activities | -246,078,338.95 | 2,115,819,098.24 |
II. Cash Flows from Investing Activities: | ||
Cash receipts from investment withdrawal | 200,000,000.00 | |
Cash receipts from return on investments | ||
Net cash receipts from disposals of fixed assets, intangible assets and other long-term assets | 2,045,652.32 | 6,080,625.78 |
Net cash receipts from disposal of subsidiary or any other business unit | ||
Other cash receipts relating to investing activities | 40,238,346.18 | |
Subtotal of cash inflow in investment activities | 2,045,652.32 | 246,318,971.96 |
Cash payments to acquire or construct fixed assets, intangible assets and other long-term assets | 419,140,143.74 | 329,149,933.00 |
Cash payments for investment | ||
Net increase in pledged loans | ||
Net cash payments to acquire subsidiary and other business units | 6,684,696.80 | |
Other cash payments relating to investment activities | 223,975,902.11 | 105,021,092.70 |
Subtotal of cash outflow in investment activities | 643,116,045.85 | 440,855,722.50 |
Net cash flow in investment activities | -641,070,393.53 | -194,536,750.54 |
III. Cash Flows from Financing Activities: | ||
Cash received from capital contributions | 2,554,868.00 | |
Including: Cash received from investment of minority shareholder from subsidiary | ||
Cash receipts from borrowings | 1,847,526,302.12 | 664,777,283.11 |
Other cash receipts relating to financing activities | ||
Subtotal of cash inflow in financing activities | 1,847,526,302.12 | 667,332,151.11 |
Cash repayments of borrowings | 548,685,558.54 | 726,328,623.21 |
Cash payments for distribution of dividends, profits, or cash payments for interest expenses | 485,401,220.11 | 248,281,618.61 |
Including: Dividends and profits paid to minority shareholders by subsidiaries | ||
Other cash paid related to financing activities | 402,261,546.21 | 971,440,749.54 |
Subtotal of cash outflow in financing activities | 1,436,348,324.86 | 1,946,050,991.36 |
Net cash flow from financing activities | 411,177,977.26 | -1,278,718,840.25 |
IV. Effect of Exchange Rate Changes on Cash and Cash Equivalents | 14,506,859.61 | 39,736,550.41 |
V. Net Increase in Cash and Cash Equivalents | -461,463,895.61 | 682,300,057.86 |
Add: Beginning balance of cash and cash equivalents | 2,076,062,785.79 | 2,032,302,255.51 |
VI. Closing Balance of Cash and Cash Equivalents | 1,614,598,890.18 | 2,714,602,313.37 |
To be a Global Leading Crop Protection Company
(II) Adjustments to relevant items in the financial statements earlier this year in light of thenew accounting standards 2023
□ Applicable ? Not applicable
(III) Audit reportWhether the Third Quarter Report is audited
□ Yes ? No
The Company's Third Quarter Report has not been audited.
In the case of any deviation from the explanations presented hereof, the Third Quarter Report of 2023 in Chinese version shallprevail.
SHANDONG WEIFANG RAINBOW CHEMICAL CO.,LTD
Board of Directors
October 31, 2023